Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors

Science
A W BannonS P Arneric

Abstract

Development of analgesic agents for the treatment of severe pain requires the identification of compounds that are devoid of opioid receptor liabilities. A potent (inhibition constant = 37 picomolar) neuronal nicotinic acetylcholine receptor (nAChR) ligand called ABT-594 was developed that has antinociceptive properties equal in efficacy to those of morphine across a series of diverse animal models of acute thermal, persistent chemical, and neuropathic pain states. These effects were blocked by the nAChR antagonist mecamylamine. In contrast to morphine, repeated treatment with ABT-594 did not appear to elicit opioid-like withdrawal or physical dependence. Thus, ABT-594 may be an analgesic that lacks the problems associated with opioid analgesia.

References

Aug 13, 1979·Life Sciences·R GamseF Lembeck
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S De Biasi, A Rustioni
Dec 1, 1982·Pharmacology, Biochemistry, and Behavior·F V AbbottB F Leber
Jul 1, 1994·Journal of Neuroscience Methods·S R ChaplanT L Yaksh
Dec 21, 1993·European Journal of Pharmacology·C QianS Ip
Jan 1, 1997·Acta Anaesthesiologica Scandinavica·T L Yaksh
Jan 1, 1997·Acta Anaesthesiologica Scandinavica·H Merskey
Dec 1, 1991·Trends in Cardiovascular Medicine·N L Benowitz

❮ Previous
Next ❯

Citations

Nov 19, 2002·Journal of Neurobiology·Fu-Ming ZhouJohn A Dani
May 15, 2001·Phytotherapy Research : PTR·G A CordellN R Farnsworth
Oct 26, 2001·Current Pain and Headache Reports·T S GrabowP S Staats
Aug 21, 2013·Biochemical Pharmacology·Iboro C UmanaDaniel S McGehee
Dec 20, 2003·Bioorganic & Medicinal Chemistry Letters·John B BremnerReginald J Smith
May 8, 2013·European Journal of Pharmacology·Lorenzo Di Cesare MannelliCarla Ghelardini
Mar 3, 2005·Pharmacology, Biochemistry, and Behavior·J W NalwalkL B Hough
Apr 20, 2000·European Journal of Pharmacology·L M Marubio, J Changeux
Apr 20, 2000·European Journal of Pharmacology·A KuryatovJ Lindstrom
Apr 20, 2000·European Journal of Pharmacology·L CurtisD Bertrand
Apr 20, 2000·European Journal of Pharmacology·A L RothD K Berg
May 17, 2000·Pharmaceutica acta Helvetiae·P A Newhouse, M Kelton
Jan 11, 2001·Pharmacology & Therapeutics·R D MacPherson
Jun 6, 2000·Trends in Pharmacological Sciences·M Cordero-ErausquinJ P Changeux
Aug 4, 1999·Trends in Pharmacological Sciences·R M EglenA Dray
Aug 27, 1999·Trends in Pharmacological Sciences·B A ChizhS Wnendt
Aug 15, 2000·Behavioural Brain Research·N BelluardoK Fuxe
Jan 4, 2001·European Journal of Medicinal Chemistry·G BalboniR Tomatis
Feb 19, 2002·Brain Research Bulletin·Edömer TassonyiDaniel Bertrand
May 7, 1999·Brain Research Bulletin·S Fürst
Aug 26, 1998·Drug and Alcohol Dependence·S J Gatley, N D Volkow
Feb 24, 2001·Journal of Chemical Neuroanatomy·J A CourtE Perry
Oct 28, 1998·Journal of Physiology, Paris·J M MatterM Ballivet
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·J M VernierI A McDonald
Sep 20, 2012·Chemical Reviews·Damien LemoineThomas Grutter
Oct 12, 2000·Acta Anaesthesiologica Scandinavica·R Pöyhiä
May 13, 2009·Acta Pharmacologica Sinica·Robert A NeffDarwin K Berg
Sep 2, 2009·Nature Reviews. Drug Discovery·Antoine TalyJean-Pierre Changeux

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.